Wow. I must say, i am impressed. Magnum seem to be quite strategic with how they are choosing to raise money. This is good imo. Didnt expect that.minimizing dilution, i dont oppose of that. Credit where credit is due, well done.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%
